Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
17%
Ph phase_4
3
50%
Ph not_applicable
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
3(60.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(2)
Other(1)

Detailed Status

Recruiting2
Completed2
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (20.0%)
Phase 43 (60.0%)
N/A1 (20.0%)

Trials by Status

not_yet_recruiting117%
unknown117%
recruiting233%
completed233%

Recent Activity

2 active trials
Showing 5 of 6
not_yet_recruitingphase_4

the Effect of Doxapram on Diaphragmatic Excursion(DE) During Weaning From Mechanical Ventilation.

NCT07637149
recruiting

Doxapram Administration on Diaphragmatic Excursion in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease Undergoing Spontaneous Breathing Trial

NCT07022704
recruitingphase_3

Doxapram Therapy in Preterm Infants (DOXA Trial)

NCT04430790
completedphase_4

Dosing Chart for Calculating the First Dose of Doxapram in Premature Infants

NCT00389909
unknownnot_applicable

The Effect and Mechanism of Respiratory Stimulant Doxapram on Facilitating Emergence

NCT02820025
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07637149Phase 4

the Effect of Doxapram on Diaphragmatic Excursion(DE) During Weaning From Mechanical Ventilation.

Not Yet Recruiting
NCT07022704

Doxapram Administration on Diaphragmatic Excursion in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease Undergoing Spontaneous Breathing Trial

Recruiting
NCT04430790Phase 3

Doxapram Therapy in Preterm Infants (DOXA Trial)

Recruiting
NCT00389909Phase 4

Dosing Chart for Calculating the First Dose of Doxapram in Premature Infants

Completed
NCT02820025Not Applicable

The Effect and Mechanism of Respiratory Stimulant Doxapram on Facilitating Emergence

Unknown
NCT02171910Phase 4

Doxapram as an Additive to Propofol Sedation in Sedation for ERCP

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6